The AIBN building officially opens.
AIBN’s first PhD student, Dr Akshat Tanksale graduates
QLD SAFI established, bringing together universities & the aviation industry to research & evaluate regional manufacture of biofuel,
Vaxxas Pty Ltd was founded to develop the Nanopatch needle-free vaccination technology.
Collaboration with Lanzatech began, with AIBN playing a key role in establishing the company’s commercial-scale gas fermentation capabilities
Creation of a molecular roadmap for the reprogramming process when adult cells are converted into artificial stem cells.
Antibody manufacture for the world-first human clinical trials to treat the Hendra virus
Fibres from Australian native spinifex grass used to improve the properties of latex, in collaboration with Dugalunji Aboriginal Corporation.
Startup company, Scaled Biolabs established to make microfluidic platforms to enable 1000s of cell experiments to run simultaneously.
A new blood test developed using gold nanoparticles to monitor individual cancer cells circulating in the body